Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia

NCT05929248 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Telitacicept
DRUG: conventional therapy
DRUG: Placebo

Sponsor

Guanmin Gao